INZY - Wall Street Estimates - Inozyme Pharma, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.565

7.19 %

$ 101 M

Market Cap

-1.01

P/E

Price Target Average

837.17%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

14.29%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Inozyme Pharma, Inc.

Wall Street analysts predict an average 1-year price target for INZY of $14.7 , with forecasts ranging from a low of $14 to a high of $16 .

INZY Lowest Price Target Wall Street Target

14 USD 794.57%

INZY Average Price Target Wall Street Target

14.7 USD 837.17%

INZY Highest Price Target Wall Street Target

16 USD 922.36%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free